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Clinics 
Age and sex: 36 year s old female patient 
Previous History:  
- no preleukemia; 
- no previous malignant disease; 
- no inborn condition of note. 
Organomegaly :  
- no hepatomegaly;  
- no splenomegaly;  
- no enlarged lymph nodes;  
- no central nervous system involvement. 
Blood 
WBC: 1.9 x 109/l; Hb: 10.0 g/dl; platelets: 41x 109/l; 
blasts: 11% 
Bone marrow: Hypercellular bone marrow, normal 
granulopoeisis depressed, blasts 31.6% (myelo 2.6%, 
metamyelo 2.8%, neutroph 6.8%, lymphocytes 37%, 
mono 0.2%, erythroblasts 19%). Blasts with moderate 
to lightly basophilic cytoplasm, azurophilic granules 
are present and occasional blasts contain Auer rods, 1-2 
nucleoli are present. 
Cytopathology classification 
Cytology: Acute myeloid leukemia. 
Immunophenotype: Not available. 
Rearranged Ig or Tcr: - 
Pathology: - 
Electron microscopy: - 
Precise diagnosis: Acute myeloid leukemia, M2. 
Survival 
Date of diagnosis: (03-2007). 
Treatment: Left for treatment abroad. 
Complete remission was obtained. Comments: Not 
known as the patient left for treatment abroad. 
Treatment related death: 
Relapse 
Phenotype at relapse 
Status: Alive (03-2007); 
Survival: 1 month. 
Karyotype 
Sample: BM; Culture time: 24 h; Banding: G-band. 
Results: 46,XY,t(3;5)(q25;q35) 
Other molecular cytogenetic techniques: Fluorescence 
in situ hybridisation (FISH), with LSI 5q EGR1 
SO/D5S23 SG) and LSI BCL6 DC probes obtained 
from Vysis (Downers Grove IL, USA). 
Other molecular cytogenetics results: Analysis with 
LSI 5q EGR1 SO/D5S23 SG probe revealed one red 
and green signal on normal chromosome 5 and on 
der(5) chromosome. Analysis with LSI BCL6 DC 
probe revealed one fusion signal on normal 
chromosome 3 and a fusion signal on der(5) distal to 
EGR1 locus confirming the t(3;5). 
Comments 
A 36-years old Kuwaiti female was referred to our 
hospital due to pancytopenia and hair loss. Initial 
investigation showed: WBC 1.9 x 109l (neutr 35%, 
lymphocy 50%, mono 2%, eos 1%, myelo 1%), blasts 
11%, NRBC 8/100. Based on laboratory findings the 
diagnosis of AML-M2 was made. 
The chromosomal translocation t(3;5)(q25;q35) was 
observed only in individual cases. From the 5 described 
cases, 3 cases (2 male 1 female) were diagnosed with 
MDS and 2 cases with AML-M6 (1 male 1 female) 
suggesting the rearrangement with possible 
involvement of NPM/MLF1 genes is associated with 
myeloid malignancies. 
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Karyotype of the patient demonstrating the t(3;5)(q25;q35). 
 
 
LSI BCL6 DC, Break Apart Rearrangement Probe exhibiting one red/green fusion on normal chromosome 3 and fusion signal on der(5) 
distal to EGR1. Hybridization with LSI 5q EGR1 SO/D5S23 SG probe on metaphase showing one red and green signal on normal and 
der(5) chromosome. 
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